+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibody Drug Conjugate Development"

ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody Generation, Antibody Origin, Antibody Isotype, Type of Payload, Type of Linker and Key Geographical Regions - Product Thumbnail Image

ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody Generation, Antibody Origin, Antibody Isotype, Type of Payload, Type of Linker and Key Geographical Regions

  • Report
  • November 2024
  • 510 Pages
  • Global
From
Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions - Product Thumbnail Image

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

  • Report
  • November 2024
  • 716 Pages
  • Global
From
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 - Product Thumbnail Image

Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030

  • Report
  • October 2024
  • 1300 Pages
  • Global
From
Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029 - Product Thumbnail Image

Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029

  • Report
  • September 2024
  • 180 Pages
  • Global
From
Antibody Drug Conjugates Contract Manufacturing Market by Linker, Condition, End Use - Global Forecast 2025-2030 - Product Thumbnail Image

Antibody Drug Conjugates Contract Manufacturing Market by Linker, Condition, End Use - Global Forecast 2025-2030

  • Report
  • October 2024
  • 196 Pages
  • Global
From
Antibody Drug Conjugates Contract Manufacturing Market Size, Share & Trends Analysis Report by Linker (Cleavable, Non-Cleavable), Condition (Myeloma, Lymphoma, Breast Cancer), and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Antibody Drug Conjugates Contract Manufacturing Market Size, Share & Trends Analysis Report by Linker (Cleavable, Non-Cleavable), Condition (Myeloma, Lymphoma, Breast Cancer), and Region with Growth Forecasts, 2025-2030

  • Report
  • February 2025
  • 100 Pages
  • Global
From
Bioconjugation Market by Bioconjugation Type (Oligonucleotide Bioconjugation, Peptide Bioconjugation, Polymer Bioconjugation), Offering (Reagents & Kits, Services), Technique, Type, End User, Applications, Therapeutic Areas - Global Forecast 2025-2030 - Product Thumbnail Image

Bioconjugation Market by Bioconjugation Type (Oligonucleotide Bioconjugation, Peptide Bioconjugation, Polymer Bioconjugation), Offering (Reagents & Kits, Services), Technique, Type, End User, Applications, Therapeutic Areas - Global Forecast 2025-2030

  • Report
  • March 2025
  • 196 Pages
  • Global
From
Antibody Drug Conjugates Contract Manufacturing Market Report 2024 - Product Thumbnail Image

Antibody Drug Conjugates Contract Manufacturing Market Report 2024

  • Report
  • November 2024
  • 175 Pages
  • Global
From
Antibody Drug Conjugates Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, Application, Target, Distribution Channel, and Geography - Product Thumbnail Image

Antibody Drug Conjugates Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, Application, Target, Distribution Channel, and Geography

  • Report
  • December 2024
  • 286 Pages
  • Global
From
Antibody Drug Conjugates Market 2025-2029 - Product Thumbnail Image

Antibody Drug Conjugates Market 2025-2029

  • Report
  • January 2025
  • 189 Pages
  • Global
From
Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • October 2022
  • 338 Pages
  • Europe, Global, Asia Pacific Europe, Global, Asia Pacific
From
ADC Cytotoxic Payloads / Warheads: Products and Services Market, 2021-2035 - Product Thumbnail Image

ADC Cytotoxic Payloads / Warheads: Products and Services Market, 2021-2035

  • Report
  • January 2022
  • 132 Pages
  • Global
From
Targeted Drug Delivery. Edition No. 1. Methods & Principles in Medicinal Chemistry - Product Thumbnail Image

Targeted Drug Delivery. Edition No. 1. Methods & Principles in Medicinal Chemistry

  • Book
  • December 2022
  • 464 Pages
  • 13 Results (Page 1 of 1)
Loading Indicator

The Antibody Drug Conjugate (ADC) Development market is a subset of the biotechnology industry that focuses on the development of drugs that combine the targeting capabilities of antibodies with the therapeutic effects of small molecules. ADCs are designed to deliver a drug directly to a specific target, such as a tumor, while minimizing the drug's effect on healthy cells. This approach has the potential to improve the efficacy and safety of cancer treatments. ADC development involves a complex process that includes the selection of an appropriate antibody, the design of a linker to attach the drug to the antibody, and the selection of a drug payload. The process also requires the development of a manufacturing process to ensure the quality and consistency of the ADC. The ADC Development market is highly competitive, with a number of companies offering products and services. Examples include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more